Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Anna-Karin Larsson-Callerfelt (Lund, Sweden), Anna-Karin Larsson-Callerfelt, Maria Weitoft, Leif Bjermer, Ellen Tufvesson, Gunilla Westergren-Thorsson. iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma. Eur Respir J 2015; 46: Suppl. 59, 2126

Member's Comments

No comment yet.

Related content which might interest you: iNOS expression is increased in peripheral airways of asthmatic patients Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Airway epithelial hemoglobin beta regulates ciliary endothelial NOS Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Activation of TLR3 augments the production of MMPs in human lung fibroblasts via iuducible NOS dependent pathway Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Nitric oxide oxidation products in bronchoalveolar lavage of patients with different severity of asthma Source: Annual Congress 2013 –Asthma Year: 2013 Alveolar nitric oxide and its role in asthma control assessment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Decreased airway eosinophilic inflammation, hypersecretion and remodeling in mice lacking all nitric oxide synthase isoforms Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Inducible nitric oxide synthase inhibition modulates lung tissue extracellular matrix remodelling induced by chronic allergic inflammation Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007 Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease Source: International Congress 2016 – Airway biomarkers Year: 2016 Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction? Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD) Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Small airway dysfunction and its role in pediatric asthma control assessment Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma Source: Eur Respir J 2006; 27: 951-956 Year: 2006 Nitric oxide modulates vascular remodelling in a model of chronic allergic lung inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 432s Year: 2006 Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen Source: Eur Respir J 2003; 21: 394-400 Year: 2003 Exhaled nitric oxide in infants: a marker of inflammation? Source: Eur Respir Monogr 2010; 49: 56-70 Year: 2010 Association of free radical formation, severity of disease and degree of systemic inflammation in patients with bronchial asthma Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Increased expression of inducible nitric oxide synthase (iNOS) in peripheral lung of severe COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002